Assessing the Effectiveness of the MedicWise Remote Monitoring App in Managing Active Inflammatory Bowel Disease Crohns and Ulcerative Colitis

What this Trial Is About

This research aims to evaluate the impact of close remote monitoring through a digital tool on disease control in patients with active Inflammatory Bowel Disease IBD, including Crohn Disease and Ulcerative Colitis. The study addresses current challenges in telemonitoring for chronic diseases, such as inconsistent results on disease control and quality of life. The MedicWise platform, which automatically collects various biological and healthcare data, is used to improve monitoring while reducing patient input. The trial is focused on assessing whether tight remote monitoring increases the time patients spend in remission and reduces IBD-related disability, while also analyzing effects on care team organization. Participants are divided into two groups, both using the MedicWise application to collect data. In the active telemonitoring group, alerts triggered by the application notify the care team, whereas in the control group, these alerts are inactive. Data are collected at baseline, 3, 6, 9, and 12 months. Each center determines how alerts are managed internally, without obligation to respond, with fixed alert thresholds throughout the study. Randomization is stratified by center and disease type. During the 12-month study, participants will provide data via the app and undergo regular evaluations including questionnaires on quality of life and IBD-related disability. Researchers will monitor time spent in symptomatic remission, healthcare contacts, medication adherence, complications, and satisfaction from both patients and care teams. The study aims to capture comprehensive outcomes related to disease control, quality of life, and healthcare usage over the year-long period.

Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases